Attendees will have a unique opportunity to learn about the Osteoarthritis Initiative, a national research study sponsored by the National Institutes of Health with the goal of advancing the understanding of the prevention and treatment of knee osteoarthritis, on Sunday, November 6 from 11:00 a.m. to noon.
To hear about the new classification criteria for axial spondyloarthritis, which may open up treatment to a new group of patients, make sure you attend the Sunday, November 6 session on “Axial Spondyloarthritis: New Concepts” from 4:30 to 6:00 p.m.
If you’re interested in optimizing your use of antimalarials in rheumatic disease, don’t miss the session, “Antimalarials for Rheumatic Disorders: Historical Perspectives, Clinical Insights, and Future Directions,” on Monday, November 7 from 9:00 to 10:00 a.m. This session will describe what is known about how antimalarials function and their role in diseases such as rheumatoid arthritis (RA), antiphospholipid syndrome, and systemic lupus erythematosus (SLE).
A session on “Adult Pharmacogenomics” on Tuesday, November 8 from 9:00 to 10:00 a.m. will tackle personalized medicine and its potential to revolutionize the way care is provided. This informative session will explore the use of gene expression markers to more precisely predict treatments that will induce a response, which means that therapies can be used more efficiently.
If after hearing the ARHP Distinguished Lecture you want to learn more about the impact of musculoskeletal conditions on function and social interaction, in addition to ways that social roles can be maintained effectively in musculoskeletal patients, don’t miss the Tuesday, November 8 session, “Beyond Pain and Fatigue: Expanding Clinician and Researcher Focus to Improve Daily Life,” from 2:30 to 4:00 p.m.
Apart from the classic musculoskeletal manifestations of RA, the eye, lungs, and heart can be directly or indirectly involved. To learn more about the extraarticular manifestations of RA, and the pathophysiologic mechanisms behind them, be sure to catch the Tuesday, November 8 session from 2:30 to 4:00 p.m.
Attendees can learn about the proper evaluation and treatment of patients with cognitive dysfunction related to SLE during a session on Tuesday, November 8 from 7:30 to 8:30 a.m.
You’re well aware that exercise can promote positive outcomes in patients with arthritis, but incorporating exercise into the lives of patients with arthritis and comorbidities can be a challenge. Learn how to design an exercise program for patients during the “Designing Exercise Prescriptions for Individuals with Arthritis and Other Comorbidities: What Are the Considerations?” session on Tuesday, November 8 from 4:30 to 6:00 p.m.
